Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated to version 2.14.1 on January 17, 2025, following the removal of version 2.14.0 on November 7, 2024.SummaryDifference1%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check93 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.